Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Greenberg

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
The American Journal of Gastroenterology|May 16, 2000
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopyP D Greenberg, L Bertario, R Gnauck, et al.
Lancet (London, England)|March 9, 1991
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinE L Cooney, A C Collier, P D Greenberg, et al.
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clonesS R Riddell, E H Warren, M A Gavin, et al.
Cytotherapy|December 11, 2002
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinomaE H Warren, S S Tykodi, M Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirusS Nagoya, P D Greenberg, C Yee, et al.
The Journal of Experimental Medicine|December 6, 2000
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligoC Yee, J A Thompson, P Roche, et al.
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
The New England Journal of Medicine|August 19, 1982
Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantationM A Cheever, A Fefer, P D Greenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
Annals of Internal Medicine|November 1, 1984
Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparisonF R Appelbaum, S Dahlberg, E D Thomas, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
The American Journal of Gastroenterology|May 16, 2000
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopyP D Greenberg, L Bertario, R Gnauck, et al.
Lancet (London, England)|March 9, 1991
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinE L Cooney, A C Collier, P D Greenberg, et al.
Cancer Journal (Sudbury, Mass.)|June 30, 2000
Immunotherapy of human viral and malignant diseases with genetically modified T-cell clonesS R Riddell, E H Warren, M A Gavin, et al.
Cytotherapy|December 11, 2002
T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinomaE H Warren, S S Tykodi, M Murata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Helper T cell-independent proliferation of CD8+ cytotoxic T lymphocytes transduced with an IL-1 receptor retrovirusS Nagoya, P D Greenberg, C Yee, et al.
The Journal of Experimental Medicine|December 6, 2000
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligoC Yee, J A Thompson, P Roche, et al.
Human Gene Therapy|June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of OncologyS R Riddell, P D Greenberg, R W Overell, et al.
The New England Journal of Medicine|August 19, 1982
Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantationM A Cheever, A Fefer, P D Greenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 proteinE L Cooney, M J McElrath, L Corey, et al.
Annals of Internal Medicine|November 1, 1984
Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparisonF R Appelbaum, S Dahlberg, E D Thomas, et al.
Pageof 16